Dachaigh › Glioma › Massachusetts
Sgrùdaidhean clionaigeach Glioma ann an Massachusetts
Tha 20 sgrùdaidhean airson Glioma a’ lorg phàirtichean aig làraichean ann an Massachusetts.
Bailtean ann an Massachusetts
Teacsa sgrùdaidh oifigeil (Beurla)
MCT for the Harvard/UCSF ROBIN Center
- Brigham and Women's Hospital, Boston
A’ fastadh
Gach aois · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06000787A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
- Dana-Farber Cancer Institute, Boston
A’ fastadhÌre 1/2
12 Months – 21 Years · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT05099003Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
- Dana Farber Cancer Institute, Boston
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT07326566A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Dana Farber Cancer Institute., Boston
A’ fastadhÌre 1/2
Suas gu aois 25 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT04094610Targeted Pediatric High-Grade Glioma Therapy
- Dana-Farber Cancer Institute, Boston
A’ fastadhSgrùdadh amharc
12 Months – 39 Years · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT05839379Study of Olutasidenib and Temozolomide in HGG
- Susan Chi, Boston
A’ fastadhÌre 2
Aoisean 12 gu 39 · Gach gnè · Air ùrachadh 1 Sult 2026 · NCT06161974SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT05303519PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- Dana-Farber Cancer Institute, Boston
A’ fastadhÌre 2
Aoisean 3 gu 39 · Gach gnè · Air ùrachadh 24 Lùna 2026 · NCT05096481Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
- Research Site, Boston
A’ fastadhÌre 1/2
Aoisean 18 gu 130 · Gach gnè · Air ùrachadh 12 Lùna 2026 · NCT05417594A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Tufts Medical Center, Boston
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
A’ fastadhÌre 2
Aoisean 8 agus nas sine · Gach gnè · Air ùrachadh 27 Iuch 2026 · NCT05503797CARv3-TEAM-E T Cells in Glioblastoma
- Massachusetts General Hospital Cancer Center, Boston
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Iuch 2026 · NCT05660369Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
- Dana-Farber Cancer Institute, Boston
A’ fastadhÌre 1 tràthFàilte do shaor-thoilich fhallain
Aoisean 1 gu 21 · Gach gnè · Air ùrachadh 29 Ògmh 2026 · NCT06333899Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Dana-Farber Cancer Institute, Boston
A’ fastadhÌre 2
12 Months – 39 Years · Gach gnè · Air ùrachadh 29 Cèit 2026 · NCT05843253Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- Dana Farber Cancer Institute, Boston
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Gibl 2026 · NCT06810544A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
- Dana-Farber Cancer Institute, Boston
A’ fastadhÌre 1 tràth
Suas gu aois 21 · Gach gnè · Air ùrachadh 18 Màrt 2026 · NCT04655404rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG
- Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston
A’ fastadhÌre 1
12 Months – 18 Years · Gach gnè · Air ùrachadh 17 Màrt 2026 · NCT04943848CUE-102 in Recurrent Glioblastoma
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Màrt 2026 · NCT06917885NeuroPathways Intervention for Brain Tumor Patients
- Massachusetts General Hospital Cancer Center, Boston
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Dùbh 2025 · NCT05976490ASCENT Intervention for Brain Tumor Patients
- Massachusetts General Hospital Cancer Center, Boston
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Iuch 2025 · NCT06099743The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
- Massachusetts General Hospital, Boston
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 90 · Gach gnè · Air ùrachadh 22 Gearr 2024 · NCT06118723Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.